Neoantigen Vaccine Spurs Broad Immune Responses
A neoantigen vaccine against 209 frameshift peptides elicited strong, broad, and long-lasting immunity in people with Lynch syndrome in a phase Ib/II study, offering a novel approach for preventing the range of cancers these individuals are at an elevated risk of developing.
Publication Details
- Journal
- Cancer Discovery
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1158/2159-8290.cd-nw2026-0012
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00